NOWDiagnostics is excited to announce that the ADEXUSDx® HIV 4th Generation Test has completed development. The test is an immunoassay used for the identification of both HIV-specific antigen p24 and HIV antibodies. With only a drop of finger stick blood, the test will accurately detect HIV in 15 minutes – and eliminate the need for external reagents and buffers.
"Once approved, the HIV 4th Generation Test will join our CE marked HIV I&II Test and our other point of care offerings" said Kevin Clark, Chief Scientific Officer at NOWDiagnostics. "We will be thrilled to offer healthcare providers yet another revolutionary rapid assay that will increase the efficiency of diagnosing this heartbreaking virus. This is another example of having our lab at the tip of your finger."
Other ADEXUSDx® brand tests include the CE marked hCG and Syphilis tests, as well as a COVID-19 Rapid Antibody Test that received FDA Emergency Use Authorization early last year. Learn more about all of the current ADEXUSDx® products here.
